In certain groups of men, glucose-6-phosphate dehydrogenase (G6PD) deficiency was linked with an increased likelihood of severe COVID-19, a Veterans Affairs cohort study found. In Black men under 65, ...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency can lead to multiple health disorders and is a serious concern globally. In a paper published in the Microchemical Journal, a ratiometric ...
Editor’s note: Each week WRAL TechWire takes a deep dive into a particular company or technology or personality. Today it’s medtech. RESEARCH TRIANGLE PARK – Baebies, a medical device and diagnostics ...
Favism is a common hereditary disease, affecting around 400 million people worldwide. It is caused by a lack of the enzyme glucose-6-phosphate dehydrogenase (G6PD). This deficiency triggers the ...
DURHAM, N.C., Nov. 9, 2022 /PRNewswire/ -- Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) ...
In their recent publication in Cell Reports, a team of scientists, led by Xiling Shen, Ph.D., Chief Scientific Officer at the Terasaki Institute for Biomedical Innovation (TIBI), has demonstrated the ...
Mitophagy is a selective form of autophagy via which the damaged mitochondria are cleared via the autophagy-lysosome pathway. Mitophagy is an essential part of mitochondrial quality control and plays ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback